Regarding OPN and RA treatment, it has been observed that low sOPN levels at baseline predict clinical remission one year after initiating tocilizumab treatment in a prospective analysis of biologic-naïve RA patients [142]. The gene discussed is SPP1; the disease is rheumatoid arthritis.